Austco Healthcare (ASX:AHC) Builds Recurring Revenue Path Through US Hospital Expansion

Aditi Sarkar

14 August 2026 04:25 PM AEST

Austco Healthcare (ASX:AHC) Builds Recurring Revenue Path Through US Hospital Expansion

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Austco Healthcare is targeting FY26 Revenue of A$90 million to A$95 million and NPAT of A$9.0 million to A$9.4 million.
The company is progressing a Pulse Mobile rollout across approximately 180 US hospitals during the 2026 calendar year.
Austco reported contract wins across New Zealand, Australia, Canada and Mexico.
The company is focused on expanding recurring software revenue alongside its healthcare communications systems.

Austco Healthcare Ltd (ASX:AHC) is advancing its healthcare communications technology strategy, with the company focused on expanding recurring software revenue through its Pulse Mobile platform and international customer base. At the time of writing on 14 August 2026, Austco Healthcare Ltd (ASX:AHC) was trading at AUD 0.23.

The company is positioning its clinical communications products as an extension of its established nurse-call systems, with the Pulse Mobile platform supporting mobile-based clinical workflows. The ongoing US rollout and FY26 financial guidance remain key areas of focus as Austco works to expand its presence in healthcare technology markets.

What Just Happened?

Austco Healthcare provided FY26 guidance indicating revenue of A$90 million to A$95 million, representing growth of 11% to 17% compared with FY25 revenue of A$81.4 million. The company also guided to net profit after tax of A$9.0 million to A$9.4 million, compared with FY25 NPAT of A$5.9 million.

Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) was guided at A$14.0 million to A$14.6 million, with gross Margin expected to reach approximately 52.8% compared with 52.0% in FY25.

The company noted that the reported NPAT outcome includes a non-cash, one-off benefit of approximately A$1.0 million from a reduction in contingent consideration. Excluding this item, Underlying Profit growth was estimated at around 35% to 40%.

A key operational update involved Pulse Mobile, with Austco stating that its largest US customer had contracted to deploy the platform across approximately 180 hospitals during the 2026 calendar year. The company also highlighted contract wins including a NZ$1.1 million project with G&S in New Zealand, an approximately A$1.1 million Warrnambool hospital project in Victoria, an approximately A$0.9 million North York General project in Canada, and a multi-year, multi-million-dollar agreement with Angeles Health System in Mexico.

Why It Matters

The Pulse Mobile deployment represents a shift toward software-based healthcare communication solutions and Recurring Revenue streams. Unlike traditional hardware sales, software and maintenance services can provide ongoing revenue opportunities once systems are deployed across healthcare networks.

A rollout across approximately 180 hospitals provides Austco with a larger installed base for its clinical communication technology and may support further customer discussions within the healthcare sector. The company’s focus on combining nurse-call infrastructure with mobile workflow solutions forms part of its broader strategy to expand beyond traditional equipment offerings.

The FY26 guidance also highlights the company’s expected financial progression, with revenue, profit and gross margin targets reflecting the company’s focus on scaling its healthcare technology operations.

The Bigger Picture

Austco Healthcare designs, manufactures and installs nurse-call systems and healthcare communication technology for hospitals and aged care facilities. Its Tacera platform supports nurse-call functionality, while Pulse Mobile provides clinical messaging and workflow capabilities connecting healthcare teams with patient-related events.

The company operates across international markets, including North America, Australia, New Zealand and other regions. Austco has continued expanding its capabilities through customer wins and acquisitions, including the planned Acquisition of Amentco under a share purchase agreement.

The company’s broader strategy involves using its installed nurse-call base to introduce additional software solutions. The transition toward recurring software revenue remains a central component of Austco’s long-term Business model.

What Could Drive the Shares Next?

The upcoming audited FY26 results will provide further detail on revenue, profitability and the contribution of underlying operating performance after adjusting for the one-off contingent consideration benefit.

The progress of the Pulse Mobile rollout across approximately 180 US hospitals will also remain a key operational milestone. Updates on deployment timing, recurring software revenue contribution and additional healthcare customer wins could influence market expectations.

Further developments from international contracts, integration of Amentco and expansion of the clinical communications pipeline will also be monitored. The company’s ability to manage operational factors while executing its growth strategy remains an important consideration.

Risks Investors Should Watch

Austco faces operational risks including Supply chain constraints, semiconductor lead times and delays in regional construction programs, which may affect revenue timing. The company also has execution exposure linked to the rollout across approximately 180 US hospitals and reliance on a major customer relationship. Reported Earnings can be affected by one-off accounting items, while acquisitions such as Amentco carry integration risks. Additional risks include currency movements, healthcare procurement cycles and competitive pressures in healthcare technology markets.

Bottom Line

Austco Healthcare Ltd (ASX:AHC) is progressing its healthcare communications strategy through the expansion of Pulse Mobile and its focus on recurring software revenue. The company is targeting FY26 revenue of A$90 million to A$95 million and NPAT of A$9.0 million to A$9.4 million, alongside a significant US hospital deployment opportunity.

The next phase will depend on delivery against FY26 guidance, execution of the Pulse Mobile rollout and continued expansion of healthcare technology contracts. Key areas for investors to monitor include underlying profitability, customer concentration, operational execution and the company’s ability to convert its installed base into recurring revenue opportunities.

FAQs

Q: What does Austco Healthcare do?

A:Austco Healthcare develops nurse-call systems and clinical communication technology for hospitals and aged care facilities.

Q: What is Pulse Mobile?

A:Pulse Mobile is Austco’s clinical communication platform designed to connect healthcare teams with patient-related events through mobile workflows.

Q: What is Austco’s FY26 revenue guidance?

A:Austco has guided to FY26 revenue of A$90 million to A$95 million.

Q: How many US hospitals are included in the Pulse Mobile rollout?

A:The company has outlined a rollout across approximately 180 US hospitals during the 2026 calendar year.

Q: What are the key risks for Austco Healthcare?

A:Key risks include execution of customer deployments, supply chain conditions, acquisition integration, competition and healthcare procurement cycles.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.